AEMD Aethlon Medical Inc

Price (delayed)

$1.79

Market cap

$1.27M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$32.92

Enterprise value

-$3.5M

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 0
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 9

Aethlon Medical, Inc. is developing the Hemopurifier ®, an investigational extracorporeal therapeutic designed to remove tumor-derived extracellular vesicles and enveloped viruses from the bloodstream. The Company is advancing the Hemopurifier ...

Highlights
The quick ratio has soared by 103% YoY and by 37% from the previous quarter
Aethlon Medical's EPS has surged by 91% YoY and by 38% QoQ

Key stats

What are the main financial stats of AEMD

AEMD stock price

How has the Aethlon Medical stock price performed over time
Intraday
-1.65%
1 week
-17.51%
1 month
-46.25%
1 year
-97.35%
YTD
-87.08%
QTD
-56.55%

Financial performance

How have Aethlon Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.08M
Net income
-$6.94M
Gross margin
N/A
Net margin
N/A
The net income has increased by 45% year-on-year and by 3% since the previous quarter
The company's operating income rose by 17% YoY and by 2.9% QoQ

Price vs fundamentals

How does AEMD's price correlate with its fundamentals

Growth

What is Aethlon Medical's growth rate over time

Valuation

What is Aethlon Medical stock price valuation
P/E
N/A
P/B
0.16
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aethlon Medical's EPS has surged by 91% YoY and by 38% QoQ
The P/B is 81% below the 5-year quarterly average of 0.9 and 58% below the last 4 quarters average of 0.4
The company's equity has surged by 52% YoY and by 6% QoQ

Efficiency

How efficient is Aethlon Medical business performance
The ROE has soared by 54% YoY and by 11% from the previous quarter
The ROA has grown by 45% YoY and by 6% from the previous quarter
Aethlon Medical's ROIC has increased by 18% YoY and by 9% from the previous quarter

Dividends

What is AEMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AEMD.

Financial health

How did Aethlon Medical financials performed over time
Aethlon Medical's current ratio has surged by 118% YoY and by 41% QoQ
The quick ratio has soared by 103% YoY and by 37% from the previous quarter
The company's debt is 95% lower than its equity
The debt to equity has dropped by 71% year-on-year and by 29% since the previous quarter
The company's debt has shrunk by 56% YoY and by 24% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.